Sorrento Therapeutics Inc (SRNE)

[dia76ca]

ANOTHER NEW PATENT APPLICATION!
United States Patent Application 20210017274
Kind Code A1
Miao; Zhenwei ; et al. January 21, 2021
Drug-Conjugates With a Targeting Molecule and Two Different Drugs

Abstract
There is disclosed an improved ADC (antibody drug conjugate) type composition having at least two different drug payloads conjugated to a single targeting protein. More specifically, the present disclosure attaches a first drug conjugate to a dual Cysteine residue on a targeting protein and a second drug conjugate with a different drug to a Lys residue on the targeting protein.